# Phenobarbital

## Phenobital inj 100mg/1mL

| 藥物代碼 | IPHE |
| :--- | :--- |
| 適應症 | Seizures. |
| 副作用 | Cardiovascular: Bradycardia, hypotension, syncope, thrombophlebitis \(IV\)Central nervous system: Agitation, anxiety, ataxia, central nervous system stimulation, central nervous system depression, confusion, dizziness, drowsiness, hallucination, hangover effect, headache, impaired judgement, insomnia, lethargy, nervousness, nightmaresDermatologic: Exfoliative dermatitis, skin rash, Stevens-Johnson syndromeGastrointestinal: Constipation, nausea, vomitingGenitourinary: OliguriaHematologic & oncologic: Agranulocytosis, thrombocytopenia, megaloblastic anemiaLocal: Pain at injection siteNeuromuscular & skeletal: Hyperkinesia, laryngospasmRespiratory: Apnea \(especially with rapid IV use\), hypoventilation, respiratory depression |
| 禁忌 | Hypersensitivity to phenobarbital, barbiturates or any component of the formulation; marked hepatic impairment; dyspnea or airway obstruction; porphyria \(manifest and latent\); intra-arterial administration, subcutaneous administration \(not recommended\); use in patients with a history of sedative/hypnotic addiction; nephritic patients \(large doses\). |
| 藥物保存方式 | 室溫 |
| 用法用量 | Adult dosing: Epilepsy \(Acute convulsions\) 20 to 320 mg IM or IV at a rate not greater than 60 mg/min; may repeat in 6 hours if needed. Sedation \(Preoperative sedation\) 100 to 200 mg IM 60 to 90 minutes prior to surgery Seizure, Emergency control of acute convulsions: 20 to 320 mg IM or IV at a rate not greater than 60 mg/min; may repeat in 6 hours if needed. Pediatric dosing: Epilepsy Usual dosage: 4 to 6 mg/kg/day IV/IM for 7 to 10 days to blood level of 10 to 15 mcg/mL or 10 to 15 mg/kg/day IV/IM. Sedation \(Preoperative sedation\) 1 to 3 mg/kg IM or IV. Seizure, Emergency control of acute convulsions: Loading doses of 15 to 20 mg/kg produce blood levels of about 20 mcg/mL shortly after administration. |
| 肝功能異常 | 需 調 整 劑 量  Use is contraindicated in marked impairment. |
| 腎功能異常 | 需 調 整 劑 量 |
| 懷孕用藥危分級 | 儘量避免 |
| 孕期用藥建議 | Human \(and animal\) data suggest risk |
| 附帶說明 | 藥品仿單:不可使用在懷孕及哺乳婦女。 |
| 哺乳期用藥建議 | No \(Limited\) Human Data - Potential Toxicity\(Mother\) 無\(很少\)資料 - 避免使用\(母體\) |
| 附帶說明 | N/A |
| 注射劑給藥建議途徑 | IM, IVD |
| 乾粉稀釋液 | N/A |
| 輸注點滴液 | 【D5W】 可選  【H/S】 可選  【N/S】 可選  【L/R】 可選  【D10W】 可選  【D5NS】 可選 |
| IVP 用法建議 | Avoid IV push. |
| IVD 用法建議 | \(Children\) Inject IV at a rate not to exceed 30 mg/min. \(Adult\) Inject IV at a rate not to exceed 60 mg/min. |
| 注意事項 | IM: Inject deeply into a large muscle. Avoid injection into or near peripheral nerves due to the risk of permanent neurological deficit. IV: Inject slowly to avoid severe respiratory depression, apnea, laryngospasm, hypertension or vasodilation with fall in blood pressure. |

## Phenobarbital 30mg

| 藥物代碼 | OPHE |
| :--- | :--- |
| 適應症 | Generalised tonic-clonic seizures, Partial seizures,  Sedation, Hypnotic. |
| 副作用 | Bradycardia, hypotension, syncope; drowsiness, lethargy, CNS excitation or depression, impaired judgment, hangover effect, confusion, somnolence, agitation, hyperkinesia, ataxia, nervousness, headache, insomnia, nightmares, hallucinations, anxiety, dizziness; rash, exfoliative dermatitis; nausea, vomiting, constipation; agranulocytosis, thrombocytopenia, megaloblastic anaemia; pain at inj site, thrombophlebitis \(IV\); oliguria: laryngospasm, respiratory depression, apnoea \(especially with rapid IV admin\), hypoventilation.Potentially Fatal: Stevens-Johnson syndrome.Neurologic: Somnolence \(1% to 3% \) |
| 禁忌 | Severe renal and hepatic disorders. Severe respiratory depression, dyspnoea or airway obstruction; porphyria. Pregnancy. |
| 藥物保存方式 | 室溫 |
| 用法用量 | Adult:For anticonvulsant:  Oral: 50-100 mg bid-tid.  IM, slow IV: 100-300 mg may be repeated in 6hrs as needed.  For hypnotic: 100-200 mg qN.  For sedative: 15-30 mg bid-tid. Child:Oral: 3-6 mg/kg in divided doses.  IM, IV: 3-5 mg/kg q3-4h as needed. |
| 肝功能異常 | 無需調整劑量  嚴重肝功能不全病患不建議使用 |
| 腎功能異常 | 無需調整劑量 |
| 懷孕用藥危分級 | 儘量避免 |
| 孕期用藥建議 | Human \(and animal\) data suggest risk |
| 附帶說明 | N/A |
| 哺乳期用藥建議 | No \(Limited\) Human Data - Potential Toxicity 無\(很少\)資料 - 避免使用 |
| 附帶說明 | N/A |
| 注射劑給藥建議途徑 | AC, P1, P2, P3, P4, PC, PO |
| 乾粉稀釋液 | N/A |
| 輸注點滴液 | N/A |
| IVP 用法建議 | N/A |
| IVD 用法建議 | N/A |
| 注意事項 | N/A |

